| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Bellah | 0 | 0% |
| Examiner Cash | 7 | 0% |
| Examiner Choudhury | 0 | 0% |
| Examiner Crow | 237 | 49% |
| Examiner Gussow (SPE) | 22 | 0% |
| Examiner Harvey-Butler | 0 | 0% |
| Examiner Hoppe | 5 | 0% |
| Examiner Kapushoc | 228 | 47% |
| Examiner Lu | 227 | 49% |
| Examiner Pohnert | 293 | 10% |
| Examiner Schloop | 6 | 0% |
| Examiner Whisenant | 258 | 79% |
| Art Unit 1683 | 1283 | 44% |
| Number | Class Description |
|---|---|
| 435 | Chemistry: molecular biology and microbiology |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 536 | Organic compounds -- part of the class 532-570 series |
| 424 | Drug, bio-affecting and body treating compositions |
| 514 | Drug, bio-affecting and body treating compositions |
| 702 | Data processing: measuring, calibrating, or testing |
| 436 | Chemistry: analytical and immunological testing |
| 800 | Multicellular living organisms and unmodified parts thereof and related processes |
| 604 | Surgery |
Art Unit 1683's grant rate is lower than that of Group 1680 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1683, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.